A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

অনুযায়ী Strati, Paolo, Nastoupil, Loretta J., Davis, Richard E, Fayad, Luis E., Fowler, Nathan, Hagemeister, Fredrick B., Kwak, Larry, Oki, Yasuhiro, Wang, Michael, Westin, Jason, Ruben, Charnelle E., Wesson, Emily T., Piekarz, Richard, Fanale, Michelle A., Lee, Hun Ju
প্রকাশিত Haematologica (2020)

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

অনুযায়ী Strati, Paolo, Chihara, Dai, Oki, Yasuhiro, Fayad, Luis E, Fowler, Nathan, Nastoupil, Loretta, Romaguera, Jorge E, Samaniego, Felipe, Garg, Naveen, Feng, Lei, Wesson, Emily T., Ruben, Charnelle E., Stafford, Mildred D., Nieto, Yago, Khouri, Issa F, Hosing, Chitra, Horowitz, Sandra B., Kamble, Rammurti T-., Fanale, Michelle A.
প্রকাশিত Haematologica (2018)